Trend and Characteristics of Acinetobacter baumannii Infections in Patients Attending Universal College of Medical Sciences, Bhairahawa, Western Nepal: A Longitudinal Study of 2018

References

• Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middle-income countries. BMJ Glob Health. 2019;4(6):e002104. doi:10.1136/bmjgh-2019-002104
   PubMed Web of Science ®Google Scholar
• Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6(1):47. doi:10.1186/s13756-017-0208-x28515903
   PubMed Web of Science ®Google Scholar
• O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist. 2014;20:1–16.
   Google Scholar
• Boucher HW, Talbot G, Bradley J. Bad bugs, no drugs: no ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis. 2009;48(1):1–12. doi:10.1086/59501119035777
   PubMed Web of Science ®Google Scholar
• Gonzalez-Villoria AM, Valverde-Garduno V. Antibiotic-resistant Acinetobacter baumannii increasing success remains a challenge as a nosocomial pathogen. J Pathog. 2016;2016:7318075. doi:10.1155/2016/731807526966582
   PubMed Web of Science ®Google Scholar
• Neidell MJ, Cohen B, Furuya Y, et al. Costs of healthcare- and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms. Clin Infect Dis. 2012;55(6):807–815. doi:10.1093/cid/cis55222700828
   PubMed Web of Science ®Google Scholar
• Lautenbach E, Synnestvedt M, Weiner MG, et al. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii. Infect Control Hosp Epidemiol. 2009;30(12):1186–1192. doi:10.1086/64845019860563
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–582.18625687
   PubMed Web of Science ®Google Scholar
• Abbott I, Cerqueira GM, Bhuiyan S, Peleg AY. Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev Anti Infect Ther. 2013;11(4):395–409. doi:10.1586/eri.13.2123566149
   PubMed Web of Science ®Google Scholar
• Pendse R, Gupta S, Yu D, Sarkar S. HIV/AIDS in the South-East Asia region: progress and challenges. J Virus Erad. 2016;2(Suppl 4):1–6.
   PubMedGoogle Scholar
• Doi Y, Murray GL, Peleg AY. Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options. Semin Respir Crit Care Med. 2015;36(1):85–98. doi:10.1055/s-0034-139838825643273
   PubMed Web of Science ®Google Scholar
• Shrestha S, Tada T, Shrestha B, et al. Emergence of aminoglycoside resistance due to arma methylase in multi-drug resistant Acinetobacter baumannii isolates in a university hospital in Nepal. J Nepal Health Res Counc. 2016;14(33):72–76.27885285
   PubMedGoogle Scholar
• Khanal BR, Wagle S, Tiwari BR. Biofilm formation and colistin susceptibility of clinical isolates of Acinetobacter species in a tertiary care hospital of Nepal. National J Lab Med. 2019;8(1):12–15.
   Google Scholar
• Koirala A, Agrahari G, Dahal N, Ghimire P, Rijal KR. ESBL and MBL mediated resistance in clinical isolates of nonfermentating Gram negative bacilli (NFGNB) in Nepal. J Microb Antimicrob Agents. 2017;3(1):18–24.
   Google Scholar
• Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: epidemiology and resistance features. Saudi J Biol Sci. 2018;25(3):586–596. doi:10.1016/j.sjbs.2016.02.00929686523
   PubMed Web of Science ®Google Scholar
• Acharya KP, Wilson RT. Antimicrobial Resistance in Nepal. Front Med. 2019;6:105. doi:10.3389/fmed.2019.00105
   Web of Science ®Google Scholar
• Amatya R, Acharya D. Prevalence of tigecycline resistant multidrug resistant Acinetobacter Calcoaceticus- Acinetobacter baumanii complex from a tertiary care hospital in Nepal. Nepal Med Coll J. 2015;17(1–2):83–86.
   Google Scholar
• Shrestha S, Tada T, Miyoshi-Akiyama T, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage. Int J Antimicrob Agents. 2015;46(5):526–531. doi:10.1016/j.ijantimicag.2015.07.01226362951
   PubMed Web of Science ®Google Scholar
• American Society for Microbiology. Manual of Clinical Microbiology. 11th ed. ASM Press, 2015.
   Google Scholar
• Kayastha K, Dhungel B, Karki S, et al. Extended-spectrum -lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting international friendship children’s hospital, Kathmandu, Nepal. Infect Dis(Auckl). 2020;13:1–7. doi:10.1177/1178633720909798
   Google Scholar
• Forbes BA, Daniel SF, Weissfelt SA. Bailey and Scott;s Diagnostic Microbiology. Mosby Publication; 2007.
   Google Scholar
• Malini A, Deepa E, Gokul B, Prasad S. Nonfermenting gram-negative bacilli infections in a tertiary care hospital in Kolar, Karnataka. J Lab Physicians. 2009;1(02):62–66. doi:10.4103/0974-2727.5970121938252
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. M100S. Accessed on; 1 20 2018.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Guragin N, Pradhan A, Dhungel B, Banjara MR, Rijal KR, Ghimire P. Extended spectrum B-lactamase producing Gram negative bacterial isolates from urine of patients visiting everest hospital, Kathmandu, Nepal. TUJM. 2019;6(1):26–31.
   Google Scholar
• Shrestha LB, Bhattarai NR, Khanal B. Comparative evaluation of methods for the detection of biofilm formation in coagulase-negative staphylococci and correlation with antibiogram. Infect Drug Resist. 2018;11:607–613. doi:10.2147/IDR.S15976429731649
   PubMed Web of Science ®Google Scholar
• Dumaru R, Baral R, Shrestha LB. Study of biofilm formation and antibiotic resistance pattern of Gram-negative Bacilli among the clinical isolates at BPKIHS, Dharan. BMC Res Notes. 2019;12(1):38. doi:10.1186/s13104-019-4084-830658694
   PubMed Web of Science ®Google Scholar
• Trojan R, Razdan L, Singh N. Antibiotic susceptibility patterns of bacterial isolates from pus samples in a tertiary care hospital of Punjab, India. Int J Microbiol. 2016;2016:9302692. doi:10.1155/2016/930269227872643
   PubMedGoogle Scholar
• Mohammadi-Mehr M, Feizabadi M. Antimicrobial resistance pattern of Gram-negative bacilli isolated from patients at ICUs of Army hospitals in Iran. Iran J Microbiol. 2011;3(1):26–30.22347579
   PubMedGoogle Scholar
• Hassanzadeh P, Motamedifar M, Hadi N. Prevalent bacterial infections in intensive care units of Shiraz University of medical sciences teaching hospitals, Shiraz, Iran. Jpn J Infect Dis. 2009;62(4):249–253.19628899
   PubMed Web of Science ®Google Scholar
• Richet H. Seasonality in Gram-negative and healthcare-associated infections. Clin Microb Infect. 2012;18(10):934–940. doi:10.1111/j.1469-0691.2012.03954.x
   Web of Science ®Google Scholar
• McDonald LC, Banerjee SN, Jarvis WR. Seasonal variation of Acinetobacter infections: 1987–1996. Nosocomial Infections Surveillance System. Clin Infect Dis. 1999;29(5):1133–1137. doi:10.1086/31344110524953
   PubMed Web of Science ®Google Scholar
• Burnham JP, Feldman MF, Calix JJ. Seasonal changes in the prevalence of antibiotic-susceptible Acinetobacter calcoaceticus-baumannii complex isolates result in increased multidrug resistance rates during winter months. Open Forum Infect Dis. 2019;6(6):245. doi:10.1093/ofid/ofz245
   Web of Science ®Google Scholar
• Prashanth K, Badrinath S. Nosocomial infections due to Acinetobacter species: clinical findings, risk and prognostic factors. Indian J Med Microbiol. 2006;24(1):39–44. doi:10.4103/0255-0857.1989316505554
   PubMedGoogle Scholar
• Van TD, Dinh QD, Vu PD, et al. Antibiotic susceptibility and molecular epidemiology of Acinetobacter calcoaceticus-baumannii complex strains isolated from a referral hospital in northern Vietnam. J Glob Antimicrob Resist. 2014;2(4):318–321. doi:10.1016/j.jgar.2014.05.00325540720
   PubMed Web of Science ®Google Scholar
• Shrestha M, Khanal B. Acinetobacter Species: phenotypic characterization and antimicrobial resistance. J Nobel Med Coll. 2013;2(1):43–48. doi:10.3126/jonmc.v2i1.7675
   Google Scholar
• Banerjee T, Mishra A, Das A, Sharma S, Barman H, Yadav G. High prevalence and endemicity of multidrug resistant Acinetobacter spp. In intensive care unit of a tertiary care hospital, Varanasi, India. J Pathog. 2018;2018:9129083. doi:10.1155/2018/912908330057820
   PubMed Web of Science ®Google Scholar
• Kanafani ZA, Zahreddine N, Tayyar R, et al. Multi-drug resistant Acinetobacter species: a seven-year experience from a tertiary care center in Lebanon. Antimicrob Resist Infect Control. 2018;7(1):9. doi:10.1186/s13756-017-0297-629387343
   PubMed Web of Science ®Google Scholar
• Raut S, Adhikari B. Ceftazidime-avibactam in ceftazidime-resistant infections. Lancet Infect Dis. 2016;16(9):997. doi:10.1016/S1473-3099(16)30194-3
   Web of Science ®Google Scholar
• Moradi J, Hashemi FB, Bahador A. Antibiotic resistance of Acinetobacter baumannii in Iran: a systemic review of the published literature. Osong Public Health Res Perspect. 2015;6(2):79–86. doi:10.1016/j.phrp.2014.12.00625938016
   PubMedGoogle Scholar
• Mishra SK, Rijal BP, Pokhrel BM. Emerging threat of multidrug resistant bugs–Acinetobacter calcoaceticus baumannii complex and methicillin resistant Staphylococcus aureus. BMC Res Notes. 2013;6(1):98. doi:10.1186/1756-0500-6-9823497675
   PubMedGoogle Scholar
• Joshi SG, Litake GM, Ghole VS, Niphadkar KB. Fluoroquinolone resistance from a transferable plasmid in Acinetobacter calcoaceticus. Indian J Pathol Microbiol. 2004;47(4):593–594.16295408
   PubMedGoogle Scholar
• Mezzatesta ML, Trovato G, Gona F, et al. In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy. Ann Clin Microbiol Antimicrob. 2008;7(1):4. doi:10.1186/1476-0711-7-418261233
   PubMedGoogle Scholar
• Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9(2):148–165. doi:10.1128/CMR.9.2.1488964033
   PubMed Web of Science ®Google Scholar
• Go ES, Urban C, Burns J, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994;344(8933):1329–1332. doi:10.1016/S0140-6736(94)90694-77968028
   PubMed Web of Science ®Google Scholar
• Gupta EMS, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Ind J Med Res. 2006;124:95–98.
   PubMed Web of Science ®Google Scholar
• Sinha M, Srinivasa H. Mechanisms of resistance to carbapenems in meropenem- resistant Acinetobacter isolates from clinical samples. Ind J Med Microb. 2007;25(2):121–125. doi:10.4103/0255-0857.32717
   Google Scholar
• Peleg AY, Potoski BA, Rea R, et al. Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report. J Antimicrob Chemother. 2007;59(1):128–131. doi:10.1093/jac/dkl44117082201
   PubMed Web of Science ®Google Scholar
• Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007;59(4):772–774. doi:10.1093/jac/dkm01817353223
   PubMed Web of Science ®Google Scholar
• Vakili B, Fazeli H, Shoaei P, et al. Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran. J Res Med Sci. 2014;19(Suppl 1):S67–S70.25002899
   PubMed Web of Science ®Google Scholar
• Montefour K, Frieden J, Hurst S, et al. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse. 2008;28(1):15–25. doi:10.4037/ccn2008.28.1.1518238934
   PubMed Web of Science ®Google Scholar
• Maragakis LL, Perl TM. Antimicrobial resistance: Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254–1263. doi:10.1086/52919818444865
   PubMed Web of Science ®Google Scholar
• Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44(8):2974–2976. doi:10.1128/JCM.01021-0616891520
   PubMed Web of Science ®Google Scholar